Skip to main content

Day: April 29, 2021

Ensysce Biosciences Receives Investigational New Drug Allowance for its Unique PF614-MPAR™ Opioid with Overdose Protection

NEW YORK and SAN DIEGO, April 29, 2021 (GLOBE NEWSWIRE) — Ensysce Biosciences, Inc. (“Ensysce”) and Leisure Acquisition Corp. (“LACQ”) (NASDAQ: LACQ, LACQU, LACQW), a special purpose acquisition company formed for the purpose of effecting a merger, acquisition or similar business combination, announced today that Ensysce has received U.S. Food and Drug Administration (“FDA”) allowance for an Investigational New Drug (IND) application for PF614-MPAR™, a two-step extended-release oxycodone prodrug which is designed to provide abuse deterrent and overdose protection properties. PF614-MPAR™ is designed as an extended-release oxycodone prodrug with both trypsin-activated abuse protection (TAAP) and overdose protection through multi-pill abuse resistance (MPAR™). TAAP chemical modification inactivates the active ingredient in PF614 and...

Continue reading

Ayurcann Enters Into Supply Agreements With Cannmart and Patient Choice

TORONTO, April 29, 2021 (GLOBE NEWSWIRE) — Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”), a Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, is pleased to announce that it has entered into two separate supply agreements with medical cannabis product suppliers, Cannmart Inc. (“Cannmart”), and Empress Agri Sales Inc. d.b.a. Patient Choice (“Patient Choice”), to sell branded products directly to medical patient consumers. The agreement between Ayurcann and Cannmart was made effective April 15, 2021, and the agreement between Ayurcann and Patient Choice was entered into on December 17, 2020. Cannmart and Ayurcann have entered into a twelve-month supply agreement with the option to renew. The terms of the agreement will see...

Continue reading

Isoray To Announce Third Quarter Fiscal 2021 Financial Results on May 13, 2021

Conference Call is Thursday, May 13 at 4:30 p.m. ET/1:30 p.m. PT RICHLAND, Wash., April 29, 2021 (GLOBE NEWSWIRE) —  Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in brachytherapy powering expanding treatment options throughout the body, today announced that it will host a conference call to discuss its financial results for the third quarter fiscal 2021 ended March 31, 2021 on Thursday, May 13, 2021, at 4:30 p.m. Eastern Time. The Company will issue a press release announcing its financial results for the third quarter fiscal 2021 after the close of the U.S. stock markets on May 13, 2021. To listen to the conference call, please dial 877-407-8035. For callers outside the U.S., please dial 201-689-8035. The conference call will be simultaneously webcast and can be accessed at   https://www.webcaster4.com/Webcast/Page/2199/40855....

Continue reading

Freddie Mac Reports First Quarter 2021 Financial Results

MCLEAN, Va., April 29, 2021 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today reported its first quarter 2021 financial results and filed its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission (SEC). The company’s Form 10-Q and press release are available now on its website, www.FreddieMac.com/investors, along with the first quarter 2021 financial results supplement. The company will hold a call at 9 a.m. Eastern Time (ET) today, April 29, 2021, to share its results with the media. The call will be concurrently webcast, and the replay will be available on the company’s website for approximately 30 days. Freddie Mac makes home possible for millions of families and individuals by providing mortgage capital to lenders. Since our creation by Congress in 1970, we’ve made housing more accessible and affordable...

Continue reading

Monster Beverage to Report Financial Results for 2021 First Quarter on May 6, 2021

Company to Conduct Conference Call at 2 p.m. Pacific Time CORONA, Calif., April 29, 2021 (GLOBE NEWSWIRE) — Monster Beverage Corporation (NASDAQ: MNST) announced today that results for its first quarter and year ended March 31, 2021 will be reported on Thursday, May 6, 2021 after the close of the market. The company also said that Co-Chief Executive Officers Rodney Sacks and Hilton Schlosberg will host an investor conference call that same day at 2 p.m. Pacific Time to review the company’s financial results and operations. The call will be open to all interested investors through a live audio webcast via the Internet at www.monsterbevcorp.com. For those who are not able to listen to the live broadcast, the call will be archived for approximately one year on the website. Monster Beverage Corporation Based in Corona, California,...

Continue reading

Nemaura Medical Issues Letter to Shareholders Following April 28 Shareholder Update Call

Loughborough, England, April 29, 2021 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today issues a Letter To Shareholders from CEO Dr. Faz Chowdhury summarizing its Shareholder Update call held yesterday, April 28, 2021. This letter is to help clarify the content from the call in which there may have been intermittent audio issues. A replay of the webcast of the call can be accessed via https://services.choruscall.com/mediaframe/webcast.html?webcastid=csR36vjo. A telephonic replay of the call will be available through May 6, 2021 and may be accessed by calling 1-877-344-7529 (U.S. domestic) or 1-412-317-0088 (international)...

Continue reading

Hampton Financial Corporation Announces Record Second Quarter 2021 Financial Results

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, April 29, 2021 (GLOBE NEWSWIRE) — Hampton Financial Corporation (“Hampton” or the “Corporation”) (TSXV:HFC & HFC.PR.A) is pleased to report the release of its unaudited condensed consolidated interim financial statements for the three and six months ended February 28, 2021. For the 2nd Quarter ended February 28, 2021 compared to the same quarter in 2020; Revenues reported were $4,580,000 vs $2,675,000; an increase of 71.2%. Net Income reported was $594,000 or $0.02 per share vs $221,000 or $0.01 per share. EBITDA reported was $1,043,000 vs $593,000. For the 6 months ended February 28, 2021 compared to the same period in 2020; Revenues reported were $6,973,000 vs $5,614,000; an increase of 24.2%. Net Income reported was $517,000...

Continue reading

Inovalon Announces 2021 Virtual Investor Day

BOWIE, Md., April 29, 2021 (GLOBE NEWSWIRE) — Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that it will host a virtual Investor Day on Tuesday, May 18, 2021 beginning at 10 a.m. ET. The virtual Investor Day is expected to run approximately 2.5 hours. Executives from Inovalon will provide an overview and discussion of the Company’s vision, growth strategy, markets, cloud-based platform capabilities, and financial information. Inovalon will webcast the event on the Investor Relations section of its website at www.inovalon.com. A replay of the event as well as a copy of all presentation materials will be available on its website following the event. About Inovalon Inovalon is a leading provider of cloud-based platforms empowering data-driven healthcare. Through...

Continue reading

OpGen to Provide Business Update and Financial Results for the First Quarter 2021 on May 13th at 8:30 a.m. Eastern Time

GAITHERSBURG, Md., April 29, 2021 (GLOBE NEWSWIRE) — OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a business update and report its first quarter 2021 financial results before the open of the U.S. financial markets on Thursday, May 13, 2021. OpGen’s management team will host a live conference call and audio webcast at 8:30 a.m. Eastern Time to discuss the Company’s financial results and provide an update on business activities.Conference Call DetailsU.S. Dial-in Number:International Dial-in Number:Webcast:Conference ID: +1 (877) 705 6003+1 (201) 493 6725http://public.viavid.com/index.php?id=14474913719409   Replay DetailsU.S. Dial-in Number:International Dial-in Number:Replay PIN: +1 (844) 512 2921+1 (412) 317 667113719409Following the conclusion of the conference...

Continue reading

WisdomTree expands digital assets range with Ethereum ETP launch

Ethereum ETP (ETHW) lists on SIX and Börse Xetra NEW YORK, April 29, 2021 (GLOBE NEWSWIRE) — WisdomTree, the exchange-traded fund (“ETF”) and exchange-traded product (“ETP”) sponsor, has announced the expansion of its digital assets range with the launch of a physically-backed1 ether ETP. The WisdomTree Ethereum ETP (ETHW) listed today on Börse Xetra and SIX, the Swiss Stock Exchange. WisdomTree now offers the lowest priced physically-backed ether and bitcoin ETPs in Europe, both with a total expense ratio of 0.95% and passported across the European Union. WisdomTree Ethereum provides investors with a simple, secure and cost-efficient way to gain exposure to the price of ether, the native currency of the Ethereum network, while utilising the best of traditional financial infrastructure and product structuring....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.